Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biodistribution of 68Ga Pentixafor in Patients With Small Cell Lung Carcinoma (SCLC)

NCT05557708 is registered in ClinicalTrials.gov with Yusuf Menda as lead sponsor.

NCT NCT05557708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05557708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biodistribution of 68Ga Pentixafor in Patients With Small Cell Lung Carcinoma (SCLC)
Lead sponsor
Yusuf Menda
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 30, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoid tumor lung, carcinoma, small-cell lung, neuroendocrine tumor of the lung